
Indian pharma wants to conquer cancer
The Daily Brief
00:00
Current trends: MAPs first, ADCs next
Akshara outlines the dominance of monoclonal antibodies now, the rising ICIs, and technical hurdles for ADCs.
Play episode from 09:30
Transcript

Akshara outlines the dominance of monoclonal antibodies now, the rising ICIs, and technical hurdles for ADCs.